Nyxoah(NYXH) ZACKS·2025-05-14 12:35分组1 - Nyxoah SA reported a quarterly loss of $0.63 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.49, and compared to a loss of $0.45 per share a year ago, indicating an earnings surprise of -28.57% [1] - The company posted revenues of $1.12 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 29.71%, and this was a decline from year-ago revenues of $1.33 million [2] - Nyxoah shares have decreased by approximately 27.8% since the beginning of the year, contrasting with the S&P 500's gain of 0.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.54 on revenues of $2.12 million, and for the current fiscal year, it is -$2.25 on revenues of $15.16 million [7] - The Medical Info Systems industry, to which Nyxoah belongs, is currently ranked in the top 20% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]